Meta-based evidence for apolipoprotein e 2/3/4 polymorphism in association with hypertension among Chinese

Journal of Human Hypertension

Volumn 25, Issue 12, 2011, Pages 725-731

  Niu, W Q ^a,b,c   Qi, Y ^d  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

^c Shanghai Institute of Hypertension   (China)

^d CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Apolipoprotein E; Association; Meta analysis; Polymorphism

Indexed keywords

APOLIPOPROTEIN E2; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4;

ALLELE; ARTICLE; CHINESE; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HUMAN; HYPERTENSION; LIPOPROTEIN METABOLISM; RISK ASSESSMENT; SYSTEMATIC REVIEW;

ADULT; AGED; ALLELES; APOLIPOPROTEIN E2; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CHINA; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; HYPERTENSION; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 81455140678     PISSN: 09509240     EISSN: 14765527     Source Type: Journal    
DOI: 10.1038/jhh.2010.116     Document Type: Article

References (28)

1. Wu Y, Huxley R, Li L, Ogaoawara AK, Dybdal N, Bunting S et al. Prevalence, awareness, treatment, and control of hypertension in China: data from the China National Nutrition and Health Survey 2002. Circulation 2008; 118: 2679-2686.
2. Yang J, Lu F, Zhang C, Liu Z, Zhao Y, Gao F et al. Prevalence of prehypertension and hypertension in a Chinese rural area from 1991 to 2007. Hypertens Res 2010; 33: 331-337.
3. Izawa H, Yamada Y, Okada T, Tanaka M, Hirayama H, Yokota M. Prediction of genetic risk for hypertension. Hypertension 2003; 41: 1035-1040. (Pubitemid 36548600)
4. Niu W, Guo X, Su Y, Qiu C. Apolipoprotein E and low-density lipoprotein receptor gene polymorphisms in dyslipidemias-associated essential hypertension. J Hum Hypertens 2007; 21: 337-339. (Pubitemid 46443598)
5. Brewer Jr HB, Zech LA, Gregg RE, Schwartz D, Schaefer EJ. NIH conference. Type III hyperlipoproteinemia: diagnosis, molecular defects, pathology, and treatment. Ann Intern Med 1983; 98: 623-640. (Pubitemid 13091177)
6. Yang R, Powell-Braxton L, Ogaoawara AK, Dybdal N, Bunting S, Ohneda O et al. Hypertension and endothelial dysfunction in apolipoprotein knockout mice. Arterioscler Thromb Vasc Biol 1999; 19: 2762-2768. (Pubitemid 29536055)
7. Niu W, Qi Y, Qian Y, Gao P, Zhu D. The relationship between apolipoprotein E epsilon2/epsilon3/epsilon4 polymorphisms and hypertension: a meta-analysis of six studies comprising 1812 cases and 1762 controls. Hypertens Res 2009; 32: 1060-1066.
8. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003; 327: 557-560. (Pubitemid 37088507)
9. Cohn LD, Becker BJ. How meta-analysis increases statistical power. Psychol Methods 2003; 8: 243-253. (Pubitemid 37268945)
10. Borenstein M, Hedges LV, Higgins JPT, Rothstein HR. Introduction to Meta-Analysis 2009. John Wiley & Sons, Ltd: Chichester, UK.
11. Hamulati W, Aisikaer Y, Yilihamujiang S. Relationship between ApoE gene polymorphism and patients of hypertension in Uighur. Chin J Immunol 2003
12. Zhimian Z, Haiqing G, Qing S, Lihua F. Clinical study of relationship between ApoE gene polymorphism and hypertension in aged. Acta Academiae Medicinae Shandong 2000; 38: 173-176.
13. Caiyou H, Chenguang Z, Zeping L, Ze Y, Jiying L, Yong W et al. The study of relation between blood pressure and apolipoprotein E genotypes in long-lived elderly in Bama area of Guangxi. Chin J Geriatr Heart Brain Vessel Dis 2007; 9: 11-13.
14. Weize Z, Xinghui L, Yongqing C, Ling M, Mingxu Z, Mian Q et al. Relationship between apolipoprotein E gene polymorphism and essential hypertension in Han, Tibetan and Hui population in high altitude area. Chin Circ J 2007; 22: 263-266.
15. Chunli R, Yingxin P, Meixia L, Ruyi L, Xue G. Analysis of apolipoprotein E gene polymorphism in hypertensive patients. Shandong Med J 2007; 47: 29-30.
16. Yingwang L, Shuiping Z, An Z, Sai N. Effect of apolipoprotein E gene polymorphism on lipid and essential hypertension. Chin J Arterioscler 2002; 10: 517-520.
17. Wen P, Siming G,Wei L, Xiaohong Z. Apolipoprotein E gene polymorphism and hypertension. J Chin Gen Pract 2003; 2: 14-15.
18. Guofang C, Zhu M, Bingxian H. Relationships between polymorphism of apoE gene and hypertension in the Han ethnics of China. Chin J Clin Rehab 2003; 7: 2545-2546.
19. Min P, Jianhua Z, Li L, Haiyan P, Huimin W, Shu L et al. Association of Apolipoprotein E with essential hypertension, NIDDM and coronary heart disease in Chinese population. Chin Synth Med 2002; 3: 1-3.
20. Li X, Du Y, Du Y, Huang X. Association of apolipoprotein E gene polymorphism with essential hypertension and its complications. Clin Exp Med 2003; 2: 175-179. (Pubitemid 36313183)
21. Ruixing Y, Jinzhen W, Weixiong L, Yuming C, Dezhai Y, Shangling P. The environmental and genetic evidence for the association of hyperlipidemia and hypertension. J Hypertens 2009; 27: 251-258.
22. Kesäniemi YA, Ehnholm C, Miettinen TA. Intestinal cholesterol absorption efficiency in man is related to apoprotein E phenotype. J Clin Invest 1987; 80: 578-581.
23. Cardon LR, Bell JI. Association study designs for complex diseases. Nat Rev Genet 2001; 2: 91-99. (Pubitemid 33674000)
24. Munafó MR, Flint J. Meta-analysis of genetic association studies. Trends Genet 2004; 20: 439-444. (Pubitemid 39094573)
25. Utermann G, Hees M, Steinmetz A. Polymorphism of apolipoprotein E and occurrence of dysbetalipoproteinaemia in man. Nature 1977; 269: 604-607.
26. Peacock ML, Fink JK. ApoE epsilon 4 allelic association with Alzheimer's disease: independent confirmation using denaturing gradient gel electrophoresis. Neurology 1994; 44: 339-341.
27. Pang CP, Baum L, Chan WM, Lau TC, Poon PM, Lam DS. The apolipoprotein E epsilon4 allele is unlikely to be a major risk factor of age-related macular degeneration in Chinese. Ophthalmologica 2000; 214: 289-291. (Pubitemid 30339158)
28. Woo D, Kaushal R, Chakraborty R, Woo J, Haverbusch M, Sekar P et al. Association of apolipoprotein E4 and haplotypes of the apolipoprotein E gene with lobar intracerebral hemorrhage. Stroke 2005; 36: 1874-1879. (Pubitemid 41266517)